Plaque Modification Devices Market Outlook Highlights Strategic Opportunities Across The Industry

The plaque modification devices market is on track for significant expansion in the coming years, driven by technological advancements and increasing demand for safer and more efficient vascular treatments. As healthcare providers focus on precision and minimally invasive procedures, this sector is expected to witness robust growth fueled by innovation and the rising prevalence of vascular diseases.

Market Size Projections and Key Growth Drivers in the Plaque Modification Devices Market
The plaque modification devices market is forecasted to reach a valuation of $2.23 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.4%. This upward trajectory is largely influenced by advancements such as AI-guided vascular imaging, the rise in complex vascular interventions, and a growing preference for safer procedural options. Additionally, the increasing volume of outpatient interventions and ongoing innovations in plaque removal technology contribute significantly to market expansion. Anticipated trends include minimally invasive plaque extraction methods, precision atherectomy innovations, enhanced embolic protection devices, sophisticated catheter-based systems, and tools designed to reduce procedure durations.

Download a free sample of the Plaque Modification Devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20928&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Organizations Steering the Plaque Modification Devices Market
Several prominent players dominate the plaque modification devices landscape, including Cardinal Health, Johnson & Johnson, Abbott Laboratories, Siemens Healthineers, Philips Healthcare, Becton dic*kinson, Stryker Corporation, Boston Scientific, Terumo Corporation, Edward Lifesciences Corporation, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, Cardiovascular Systems Inc. (CSI), ACIST Medical Systems Inc., Endologix Inc., Avinger Inc., and SoundBite Medical Solutions Inc.
In May 2024, Johnson & Johnson expanded its cardiovascular portfolio by acquiring Shockwave Medical Inc., a US-based developer of plaque modification technologies. This strategic acquisition is expected to bolster Johnson & Johnson's offerings with Shockwave's intravascular lithotripsy technology aimed at treating calcified arterial plaques, with projections to generate at least $1 billion in annual sales and address unmet needs in coronary and peripheral artery disease treatments.

Emerging Trends Highlighting Innovation and Competitive Advantage in Plaque Modification Devices
Companies in this market are increasingly focusing on developing cutting-edge intravascular image-guided, catheter-based systems to maintain a competitive edge. Intravascular image-guidance involves using imaging technology to precisely navigate devices within blood vessels, enhancing procedural accuracy and outcomes.
For example, in August 2024, Avinger unveiled the Pantheris LV system, a directional atherectomy device designed for treating peripheral artery disease in larger vessels like the superficial femoral and popliteal arteries. The system features higher-speed plaque removal for difficult occlusions, a proprietary jog mechanism for improved plaque contact, and an advanced guidewire management system to simplify operation and increase efficiency.

View the full Plaque Modification Devices market report:
https://www.thebusinessresearchcompany.com/report/plaque-modification-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

In-Depth Segmentation Overview of the Plaque Modification Devices Market
The plaque modification devices market is categorized into several segments for better analysis:
1) By Device Type: Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, and Embolic Protection Devices.
2) By Application Area: Coronary Artery Disease, Peripheral Artery Disease, and Neurovascular Diseases.
3) By End User: Hospitals, Ambulatory Surgical Centers, and Other End Users.

Detailed subcategories include:
- Atherectomy Devices: Rotational, Directional, Laser, and Orbital Atherectomy Devices.
- Thrombectomy Devices: Mechanical, Aspiration, Manual, and Hybrid Thrombectomy Devices.
- Chronic Total Occlusion Devices: CTO Crossing Guidewires, CTO Balloons, CTO Catheters, and CTO Support Systems.
- Embolic Protection Devices: Distal Protection, Proximal Protection, Filter-Based, and Balloon-Based Embolic Protection Devices.

This comprehensive segmentation helps in understanding the diverse product types, applications, and end-user preferences that shape the plaque modification devices market dynamics globally.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.